Quality Prescribing Strategy for Respiratory: A Guide for Improvement 2024-2027
(2024)
Report
Anderson, D., Fardon, T., Mair, A., Korsah, P., Smith, G., Strath, A., McMahon, A., & Leitch, J. (2024). Quality Prescribing Strategy for Respiratory: A Guide for Improvement 2024-2027
All Outputs (5)
Medication without harm: policy brief (2024)
Report
Galappatthy, P., Mair, A., & Dhingra-Kumar, N. (2024). Medication without harm: policy brief. Geneva: World Health Organization
Scottish Drug Checking Project summary (2024)
Report
Carver, H., Falzon, D., Aston, E., Craik, V., Masterson, W., & Parkes, T. (2024). Scottish Drug Checking Project summary. Corra Foundation
Literature Review on Antimicrobial Resistance In Relation To The Environment In Scotland (2024)
Report
Wojcik, G., Anderson, L., Johnston, L., Moffat, S., & Morrison, D. (2024). Literature Review on Antimicrobial Resistance In Relation To The Environment In Scotland. Environmental Standards ScotlandCommissioned literature review on the key causes, impacts and controls for anti-microbial resistance (AMR) in the environment that are relevant to Scotland. The review summarises what is currently known about the impact of AMR on the environment and... Read More about Literature Review on Antimicrobial Resistance In Relation To The Environment In Scotland.
Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027 (2024)
Report
Mair, A., Kennon, B., Chalmers, J., Smith, G., Strath, A., McMahon, A., & Leitch, J. (2024). Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027. Scottish GovernmentThis quality prescribing guide is intended to support clinicians across the multidisciplinary team and people with Type 2 Diabetes Mellitus (T2DM) in shared decision-making and the effective use of medicines, and offers practical advice and options f... Read More about Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027.